HOME
CAREERS
CONTACT US
KOREAN
ENGLISH
KR
EN
Toggle navigation
COMPANY
ABOUT US
KEY MEMBERS
HISTORY
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARD
SCIENCE
NT-I7
NeoBase
NT2020
NT3020
NT4010
NT5010
PIPELINE
Clinical
R&D
COLLABORATION
INVESTORS
NOTICE
PRESENTATION
GENERAL MEETING
OF STOCKHOLDERS
INDEPENDENT
AUDITOR'S REPORT
CONTACT IR
MEDIA
NEWS
VIDEO SOURCE
ESG
OVERVIEW
ENVIRONMENTAL
SOCIAL
GOVERNANCE
NOTICE
HOME
INVESTORS
NOTICE
NOTICE
Total
4
4
Discontinuance of Certain Clinical Trials and Strengthened Focus on Development Priorities
2023-07-17
3
Discontinuance NIT-116 Clinical trial for COVID-19 patients
2023-03-10
2
Guidance Notes for Company Organizational Changes
2022-07-21
1
NeoImmuneTech Internal Information Management Policy
2022-03-31
1
Search